Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.5 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |